Related Experiment Video
Updated: May 3, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Yngvar Fløisand1, Klaus Beiske2, Geir Erland Tjønnfjord3
1Department of Hematology, University of Oslo, P.O. Box 4950, Nydalen, 0424 Oslo, Norway.
This study reports a rare case of a malignant phyllodes tumor followed by acute megakaryoblastic leukemia in a female patient. Karyotype analysis suggests both malignancies originated from the same clonal process, a phenomenon previously observed in mediastinal germ cell tumors.
Area of Science:
- Oncology
- Hematology
- Genetics
Background:
- Mediastinal germ cell tumors (GCT) in males are associated with hematologic malignancies, particularly acute megakaryoblastic leukemia.
- These malignancies share a common clonal origin, often indicated by isochromosome 12p (i(12p)).
Purpose of the Study:
- To investigate the potential common clonal origin between a malignant phyllodes tumor and subsequent acute megakaryoblastic leukemia in a female patient.
- To explore if phyllodes tumors can undergo leukemic transformation similar to mediastinal GCT.
Main Methods:
- Karyotype analysis of cells from both the phyllodes tumor and the acute megakaryoblastic leukemia.
- Comparison of marker chromosomes between the two malignancies to infer clonal origin.
Main Results:
- Identical marker chromosomes were identified in cells from both the malignant phyllodes tumor and the acute megakaryoblastic leukemia.
- This finding implies a shared clonal origin for both malignancies in the patient.
Conclusions:
- This case suggests that malignant phyllodes tumors, like mediastinal GCT, can potentially undergo leukemic transformation.
- The findings highlight a possible shared mechanism of clonal evolution in distinct tumor types leading to hematologic malignancies.
More Related Videos
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Differentiation of Common Myeloid Progenitor Cells
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Abnormal Proliferation